Although patients at risk for diabetes (ie, prediabetes, defined as a hemoglobin A1C 5.7% to 6.4% or a fasting blood glucose level 100 to 125 mg/dL) were included in FDA registration trials of Saxenda or Wegovy, prediabetes is not an FDA indication for any GLP-1 agonist
These results are consistent with reports that patients treated with semaglutide notice reduced interest in consuming addictive substances including alcohol or tobacco [12]
On Thursday, Eli Lilly announced promising Phase 3 results for orforglipron, its once-daily oral GLP-1 pill
Pairing with other daily supplements BPC-157 pairs well with a couple of complementary supplements, depending on whether your focus is digestion or cellular health
Lemon Bottle offers lower cost and potentially gentler treatment without scientific validation of efficacy or safety
Non-GLP-1 weight loss medications Other non-GLP-1 medications that may support your weight loss program include: Metformin: Metformin (Glumetza and Fortamet) is a pill used to treat type 2 diabetes by helping control blood sugar levels